AChEi	Acetylcholinesterase inhibitors
AChR	Acetylcholine receptor
ADAM22	ADAM metallopeptidase domain 22
ADAMTS13	A disintegrin and metalloprotease with thrombospondin type 1 motif 13
ADCC	Antibody-dependent cellular cytotoxicity
AIDP	Acute inflammatory demyelinating polyneuropathy
AMPAR	α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor
Bregs	Regulatory B-cells
Caspr2	Contactin associated protein 2
CCL3	C-c motif chemokine ligand 3
CIDP	Chronic inflammatory demyelinating polyneuropathy
CNTN1	Contactin 1
DPPX	Dipeptidyl-peptidase–like protein-6
Dsg-1 Dsg-3	Desmoglein-1, desmoglein-3
EAMG	Experimental autoimmune myasthenia gravis
FAE	Fab-arm exchange
GABAaR	Gamma-aminobutyric acid a receptor
GABAbR	Gamma-aminobutyric acid b receptor
GITR	Glucocorticoid-induced tumour necrosis factor receptor-related protein
GITR-L	GITR- ligand
GM-CSF	Granulocyte macrophage colony-stimulating factor
HLA	Human lymphocyte antigen
IFN-γ	Interferon gamma
IgG4-AID	IgG4 autoimmune diseases
IgG4-RLD	IgG4 related disease
IgLON5	Immunoglobulin-like cell adhesion molecule 5
IL	Interleukin (IL-4
IL-10	IL-13)
IL-4Rα	Interleukin 4 receptor alpha
IVIG	Intravenous immunoglobulin
KO	Knock out
LGI1	Leucine rich glioma inactivated 1
LRP4	Low density lipoprotein receptor-related protein 4
MG	Myasthenia gravis
MN	Membranous nephropathy
MuSK	Muscle specific kinase
NMDAR	N-methyl-D-aspartate receptor
PBMC	Peripheral blood mononuclear cell
PF	Pemphigus foliaceus
PLA2R	Phospholipase A2 receptor
PLEX	Plasmapheresis or plasma exchange
PV	Pemphigus vulgaris
TNF-α	Tumor necrosis factor alpha
Tregs	Regulatory T cells
THSD7A	Thrombospondin type 1 domain containing 7a
TTP	Thrombotic thrombocytopenic purpura
vWF	Von Willebrand factor